Ascendis Pharma

Ascendis Pharma is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs. They utilize their proprietary TransCon technology to create prodrugs that release active ingredients in a controlled manner, enhancing efficacy and safety. Founded in 2007 and headquartered in Hellerup, Denmark, Ascendis Pharma has a robust pipeline targeting endocrinology, oncology, and rare diseases. Their revenue primarily comes from product sales, collaborations, and licensing agreements. Notably, their lead product, TransCon Growth Hormone, has shown promising results in clinical trials, positioning the company as a leader in the biopharma industry.

Recent Posts by Ascendis Pharma

1-20 of 31